+ Watch INCY
on My Watchlist
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.
I think Incyte needs a secondary source of revenue besides its main drug, Jakafi, and in the meantime, shares have run up based on Jakafi's success.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions